Michiya Ohno

1.7k total citations
23 papers, 1.4k citations indexed

About

Michiya Ohno is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Michiya Ohno has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 8 papers in Nephrology and 5 papers in Molecular Biology. Recurrent topics in Michiya Ohno's work include Cardiovascular Function and Risk Factors (6 papers), Dialysis and Renal Disease Management (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Michiya Ohno is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Dialysis and Renal Disease Management (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Michiya Ohno collaborates with scholars based in Japan, United States and Nepal. Michiya Ohno's co-authors include Hisayoshi Fujiwara, Takako Fujiwara, Jun Misao, Yukihiro Hayakawa, William C. Little, Che‐Ping Cheng, Shinya Minatoguchi, Genzou Takemura, Satoshi Kato and Dalane W. Kitzman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michiya Ohno

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michiya Ohno Japan 11 811 545 262 175 172 23 1.4k
Marc J. Semigran United States 7 786 1.0× 645 1.2× 217 0.8× 337 1.9× 80 0.5× 8 1.4k
Masanori Kawaguchi Japan 10 460 0.6× 510 0.9× 138 0.5× 404 2.3× 93 0.5× 26 1.1k
Mihály Ruppert Hungary 21 622 0.8× 360 0.7× 118 0.5× 303 1.7× 64 0.4× 72 1.2k
Yukihiro Seta United States 13 1.3k 1.6× 751 1.4× 175 0.7× 256 1.5× 44 0.3× 21 1.9k
Toshiaki Kadokami Japan 22 1.1k 1.3× 528 1.0× 104 0.4× 332 1.9× 195 1.1× 68 1.8k
Qiang Su China 20 272 0.3× 451 0.8× 136 0.5× 151 0.9× 114 0.7× 48 947
Yukun Luo China 17 298 0.4× 406 0.7× 223 0.9× 284 1.6× 140 0.8× 63 1.2k
Takeshi Niizeki Japan 24 788 1.0× 408 0.7× 71 0.3× 157 0.9× 137 0.8× 53 1.5k
Lichan Tao China 18 630 0.8× 665 1.2× 96 0.4× 165 0.9× 59 0.3× 31 1.6k
Gustavo E Crespo-Avilan Singapore 10 466 0.6× 607 1.1× 260 1.0× 190 1.1× 46 0.3× 13 1.2k

Countries citing papers authored by Michiya Ohno

Since Specialization
Citations

This map shows the geographic impact of Michiya Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiya Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiya Ohno more than expected).

Fields of papers citing papers by Michiya Ohno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiya Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiya Ohno. The network helps show where Michiya Ohno may publish in the future.

Co-authorship network of co-authors of Michiya Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of Michiya Ohno. A scholar is included among the top collaborators of Michiya Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiya Ohno. Michiya Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Naito, Junko, Hiroshige Ohashi, Michiya Ohno, et al.. (2019). Long-Term Levocarnitine Ameliorates Left Ventricular Diastolic as Well as Systolic Dysfunction in Hemodialysis Patients ― Multi-Center Study ―. Circulation Reports. 1(11). 508–516. 4 indexed citations
4.
Ohno, Michiya, Hiroshi Sarui, Akihiko Sasaki, et al.. (2014). Correlation between Renal Function and Common Risk Factors for Chronic Kidney Disease in a Healthy Middle-Aged Population: A Prospective Observational 2-Year Study. PLoS ONE. 9(11). e113263–e113263. 9 indexed citations
5.
Miyazaki, Nagisa, Ichijiro Murata, Genzou Takemura, et al.. (2014). Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy.. PubMed. 7(11). 7485–96. 8 indexed citations
6.
Ohno, Michiya, Hiroshige Ohashi, Hiroshi Oda, et al.. (2012). Lanthanum Carbonate for Hyperphosphatemia in Patients on Peritoneal Dialysis. Peritoneal Dialysis International. 33(3). 297–303. 3 indexed citations
7.
Minatoguchi, Shinya, et al.. (2008). Dual blockade of the rennin–angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Clinical and Experimental Nephrology. 12(1). 33–40. 8 indexed citations
8.
Kato, Yoko, et al.. (2007). Efficacy and pleiotropic effects of a new HMG-CoA reductase inhibitor, Rosuvastatin, in peritoneal dialysis patients with dyslipidemia. Nihon Toseki Igakkai Zasshi. 40(9). 781–787. 1 indexed citations
9.
Hasegawa, Hiroshi, William C. Little, Michiya Ohno, et al.. (2003). Diastolic mitral annular velocityduring the development of heart failure. Journal of the American College of Cardiology. 41(9). 1590–1597. 124 indexed citations
10.
Takada, Nobuyuki, et al.. (2003). C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. American Journal of Kidney Diseases. 42(2). 355–361. 39 indexed citations
11.
Yamashita, Kazuya, Shinya Minatoguchi, Yoshihiro Uno, et al.. (2000). T‐0162, A Novel Free Radical Scavenger, Reduces Myocardial Infarct Size In Rabbits. Clinical and Experimental Pharmacology and Physiology. 27(3). 172–178. 3 indexed citations
12.
Jiang, Xiaowen, et al.. (2000). Apoptosis in microvascular endothelial cells of perfused rabbit lungs with acute hydrostatic edema. Journal of Applied Physiology. 88(2). 518–526. 6 indexed citations
13.
Ohashi, Hiroshige, Hiroshi Oda, Michiya Ohno, Sachiro Watanabe, & Shigeki Sakata. (1999). Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients. Kidney International. 56. S242–S244. 34 indexed citations
14.
Hayakawa, Yukihiro, Genzou Takemura, Jun Misao, et al.. (1999). Apoptosis and Overexpression of Bax Protein and bax mRNA in Smooth Muscle Cells Within Intimal Hyperplasia of Human Radial Arteries. Arteriosclerosis Thrombosis and Vascular Biology. 19(9). 2066–2077. 19 indexed citations
15.
Takemura, Genzou, Michiya Ohno, Yukihiro Hayakawa, et al.. (1998). Role of Apoptosis in the Disappearance of Infiltrated and Proliferated Interstitial Cells After Myocardial Infarction. Circulation Research. 82(11). 1130–1138. 168 indexed citations
16.
Ohno, Michiya, Genzou Takemura, Atsuko Ohno, et al.. (1998). “Apoptotic” Myocytes in Infarct Area in Rabbit Hearts May Be Oncotic Myocytes With DNA Fragmentation. Circulation. 98(14). 1422–1430. 260 indexed citations
18.
Misao, Jun, Yukihiro Hayakawa, Michiya Ohno, et al.. (1996). Expression of bcl-2 Protein, an Inhibitor of Apoptosis, and Bax, an Accelerator of Apoptosis, in Ventricular Myocytes of Human Hearts With Myocardial Infarction. Circulation. 94(7). 1506–1512. 314 indexed citations
19.
Little, William C., Michiya Ohno, Dalane W. Kitzman, James D. Thomas, & Che‐Ping Cheng. (1995). Determination of Left Ventricular Chamber Stiffness From the Time for Deceleration of Early Left Ventricular Filling. Circulation. 92(7). 1933–1939. 253 indexed citations
20.
Arakawa, Masaaki, Hiroshi Miwa, Michiya Ohno, et al.. (1992). Changes in plasma concentrations of atrial natriuretic peptides after cardioversion of chronic atrial fibrillation. The American Journal of Cardiology. 70(4). 550–552. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026